[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369005-105":59,"doc-detail-369005-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","subtype-specific-mrna-signatures-of-human-ribosomal-proteins-in-pediatric-cancers","Subtype-Specific mRNA Signatures of Human Ribosomal Proteins in Pediatric Cancers","","A growing body of recent work suggests heterogeneous ribosomal composition, raising the question of whether subtype-specific ribosomal protein (RP) mRNA signatures occur in pediatric cancers. The study analyzed mRNA expression data from multiple large pediatric cancer datasets to test heterogeneity in RP mRNA signatures. Pediatric cancer types showed distinct RP mRNA signatures, sometimes multiple subtypes within a single cancer type, including subgroup/subtype- or cell-of-origin-specific patterns. In B-cell acute lymphoblastic leukemia, two RP mRNA subtypes had significantly different prognoses. Results support a heterogeneous, subtype-specific RP mRNA signature in pediatric cancer with potential clinical relevance.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/subtype-specific-mrna-signatures-of-human-ribosomal-proteins-in-pediatric-cancers/369005/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/subtype-specific-mrna-signatures-of-human-ribosomal-proteins-in-pediatric-cancers/369005.png","ImageObject",300,407,{"name":92,"@type":93},"dhado","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What question does the study address about ribosomal protein signatures in pediatric cancers?","Question",{"text":113,"@type":114},"The study tests whether subtype-specific RP mRNA signatures, previously observed in adult cancers, are also present in human pediatric cancers.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did the authors evaluate RP mRNA heterogeneity?",{"text":118,"@type":114},"They analyzed mRNA expression data from multiple large pediatric cancer datasets and focused on RP genes, using normalization to remove inter-sample variation in total RP mRNA.",{"name":120,"@type":111,"acceptedAnswer":121},"What key finding was observed in B-cell acute lymphoblastic leukemia (ALL)?",{"text":122,"@type":114},"B-cell ALL showed two RP mRNA subtypes with significantly different prognoses, indicating clinically relevant molecular heterogeneity.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},369005,1790331052,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41,"preview_page_count":19,"preview_urls":146},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Brief Report  \nSubtype-Specific mRNA Signatures of Human Ribosomal Proteins in Pediatric Cancers  \nAnshuman Panda 1,2,3, Anupama Yadav 4,5, Gyan Bhanot 3,6 and Shridar Ganesan 1,2,3,7, *  \nAcademic Editor: Naoyuki Kataoka  \nReceived: 3 November 2025  \nRevised: 9 December 2025  \nAccepted: 12 December 2025  \nPublished: 14 December 2025  \nCitation: Panda, A.; Yadav, A.; Bhanot, G.; Ganesan, S. SubtypeSpecific mRNA Signatures of Human Ribosomal Proteins in Pediatric Cancers. Int. J. Mol. Sci. 2025, 26, 12036. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms262412036  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Perlmutter Cancer Center, New York, NY 10016, USA; [ap1022@scarletmail.rutgers.edu](ap1022@scarletmail.rutgers.edu)  \n2 NYU Grossman School of Medicine, New York, NY 10016, USA  \n3 Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA  \n4 Dana-Farber Cancer Institute, Boston, MA 02215, USA  \n5 Harvard Medical School, Boston, MA 02115, USA  \n6 Departments of Molecular Biology & Physics, Rutgers University, Piscataway, NJ 08854, USA  \n7 Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA  \n* Correspondence: [shridar.ganesan@nyulangone.org](shridar.ganesan@nyulangone.org)  \nAbstract  \nA growing body of recent work suggests the possibility of heterogeneous ribosomal composition. We recently observed subtype-specific mRNA and copy number variation signatures of human ribosomal proteins (RPs) in cancers from human adults, but whether such subtype-specific RP mRNA signatures are also present in human pediatric cancers is currently unknown. In this study, we analyzed mRNA expression data from multiple large pediatric cancer datasets to test for heterogeneity in RP mRNA signatures. We found that different pediatric cancer types have different RP mRNA signatures, sometimes multiple RP mRNA signatures within the same pediatric cancer type, which can be subgroup/subtype-specific (e.g., in Medulloblastoma) or cell-of-origin-specific (e.g., in Acute Lymphoblastic Leukemia (ALL)) . In B-cell ALL, we found two RP mRNA subtypes with significantly different prognoses. Consistent with our recent findings in adult cancers, the RP mRNA signature in pediatric cancer is heterogeneous and subtype-specific and may have clinical relevance.  \nKeywords: ribosomal proteins; pediatric cancers; medulloblastoma; acute lymphoblastic leukemia; heterogeneous ribosomal composition  \n1. Introduction  \nThe ribosome is conventionally believed to have homogeneous composition [1] with fixed stoichiometry [2] among core ribosomal proteins (RPs) . Consequently, unlike other genes, the RP mRNA pattern is conventionally expected to be relatively uniform apart from inter-sample variation in the total RP level. However, previous work by our group [3,4] and others [1,2,5–7] suggest the possibility that the ribosome may not be monolithic and may have a heterogeneous composition in response to extra/intracellular stimuli. Specifically, ina recent study [3], we observed subtype-specific mRNA and copy number variation (CNV) signatures of RPs in cancers from human adults. Among other results, we found that inhuman adults, different cancer types, and sometimes different subtypes of the same cancer type, often have different RP mRNA signatures [3], even after accounting for trivial intersample variation in total RP mRNA. Several adult cancer types were found to have multiple RP mRNA subtypes, with significant survival and genomic differences between these RP  \nmRNA subtypes [3] . Whether such heterogeneity in RP mRNA signatures, with potential clinical relevance, is also present in human pediatric cancers is curren","cbCainzMXcMLuwzK","https://ap.wps.com/l/cbCainzMXcMLuwzK","pdf",2082429,12,"English","# Abstract\n# 1. Introduction\n# 2. Results\n## 2.1. Subtype-Specific RP mRNA Signature in Pediatric Cancers from TARGET","[{\"question\":\"What question does the study address about ribosomal protein signatures in pediatric cancers?\",\"answer\":\"The study tests whether subtype-specific RP mRNA signatures, previously observed in adult cancers, are also present in human pediatric cancers.\"},{\"question\":\"How did the authors evaluate RP mRNA heterogeneity?\",\"answer\":\"They analyzed mRNA expression data from multiple large pediatric cancer datasets and focused on RP genes, using normalization to remove inter-sample variation in total RP mRNA.\"},{\"question\":\"What key finding was observed in B-cell acute lymphoblastic leukemia (ALL)?\",\"answer\":\"B-cell ALL showed two RP mRNA subtypes with significantly different prognoses, indicating clinically relevant molecular heterogeneity.\"}]","Subtype-Specific mRNA Signatures of Human Ribosomal Proteins in Pediatric Cancers | PDF",1790180127,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7667d602ee3e68f651e141d7ab7db611.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34a9c0b08116e967d7407d04ba55b317.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/697961d35e5b4cc399525aa39d0b9e4f.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cdc0c3eb1a1b790f1d3e5bcedfd50c18.webp",980,1385]